tiprankstipranks
BioCryst sees FY25 ORLADEYO revenue between $515M-$535M
PremiumThe FlyBioCryst sees FY25 ORLADEYO revenue between $515M-$535M
8d ago
BioCryst reports Q4 preliminary revenue $130.8M, consensus $128.65M
Premium
The Fly
BioCryst reports Q4 preliminary revenue $130.8M, consensus $128.65M
8d ago
BioCryst reports inducement grants under Nasdaq listing rule
Premium
The Fly
BioCryst reports inducement grants under Nasdaq listing rule
12d ago
BioCryst price target raised to $8 from $7 at Barclays
PremiumThe FlyBioCryst price target raised to $8 from $7 at Barclays
2M ago
BioCryst Pharmaceuticals Reports Strong Q3 2024 Results
Premium
Company Announcements
BioCryst Pharmaceuticals Reports Strong Q3 2024 Results
2M ago
Nvidia to replace Intel on DJIA, Berkshire reports Q3 results: Morning Buzz
Premium
The Fly
Nvidia to replace Intel on DJIA, Berkshire reports Q3 results: Morning Buzz
2M ago
BioCryst Pharmaceuticals (BCRX) Q3 Earnings Cheat Sheet
PremiumPre-EarningsBioCryst Pharmaceuticals (BCRX) Q3 Earnings Cheat Sheet
3M ago
BioCryst presents evidence on high adherence, persistence rates with ORLADEYO
Premium
The Fly
BioCryst presents evidence on high adherence, persistence rates with ORLADEYO
3M ago
BioCryst to present real-world evidence on oral ORLADEYO
Premium
The Fly
BioCryst to present real-world evidence on oral ORLADEYO
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100